James Skaggs

Director at Aminex Therapeutics.

Raised on Aminex Therapeutics filings

$15.1M

of $30M offered across 1 Form D filing

Company

Biotech · Kenmore, WA

Polyamine-depleting oral therapy for solid tumors

Polyamine-depleting oral therapy for solid tumors

Aminex Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Dec 5, 2025	Equity	$15.1M/ $30M	Form D

Also named on Aminex Therapeutics filings